P. Fumoleau

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

C. Focan, S. M. Steinberg, M Blichert-Toft et al. · PubMed · 1998 · 2.2K citations

Medicine, Oncology, Pharmacotherapy +5

Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results

Joyce O’Shaughnessy, David Miles, Svetislava J. Vukelja et al. · Journal of Clinical Oncology · 2002 · 1.1K citations

Medicine, Oncology, Pharmacology +14

Identification of molecular apocrine breast tumours by microarray analysis

Pierre Farmer, Hervé Bonnefoi, Véronique Becette et al. · Oncogene · 2005 · 767 citations · Full text

Medicine, Molecular Biology, Oncology +14

Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy

José Baselga, Karen A. Gelmon, Shailendra Verma et al. · Journal of Clinical Oncology · 2010 · 640 citations · Full text

Medicine, Oncology, Pharmacology +17

Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial

Henri Roché, P. Fumoleau, M. Spielmann et al. · Journal of Clinical Oncology · 2006 · 572 citations · Full text

Medicine, Oncology, Pharmacology +16